Investigators conducted a randomized clinical trial to evaluate the impact of an online, single-day cognitive behavioral therapy program on women with postpartum depression.
A team of investigators conducted a cross-sectional study to explore the association between an increased pain threshold and risk of self-harm in youth.
Women with age-related loss of muscle mass may experience fewer hot flashes at menopause.
Enrollment in an automated remote monitoring service for adults with COVID-19 at home can help reduce mortality.
Using the ACR/EULAR criteria, researchers studied the population-based incidence, prevalence, and mortality of dermatomyositis in adults.
Investigators conducted a cohort study to assess the impact of electroconvulsive therapy on suicide risk in patients with major depressive disorder.
In an observational study, researchers assessed outcomes from mobile stroke units or emergency medical services within 4.5 hours after onset of acute stroke symptoms.
Nine in 10 teens and young adults report using sunscreen.
Celecoxib may be safe and effective for the treatment of acute migraine and migraine-associated symptoms among patients with episodic migraine.
Pfizer Inc. announced that it has reached an agreement for its promising COVID-19 antiviral pill to be made and sold cheaply in 95 developing nations.